Trial Profile
Randomized PhaseII/III Trial of XL-184 versus Liposomal Doxorubicin in Recurrent Platinum Resistant/Refractory Peritoneum
Status:
Planning
Phase of Trial:
Phase II/III
Latest Information Update: 06 Oct 2011
Price :
$35
*
At a glance
- Drugs Cabozantinib (Primary) ; Doxorubicin liposomal (Primary)
- Indications Gynaecological cancer; Peritoneal cancer
- Focus Therapeutic Use
- 06 Oct 2011 New trial record